Published in Adv Enzyme Regul on March 18, 2008
Protein kinase Calpha: disease regulator and therapeutic target. Trends Pharmacol Sci (2009) 1.25
Protein kinase Cι expression and oncogenic signaling mechanisms in cancer. J Cell Physiol (2011) 1.08
Atypical protein kinase Cι as a human oncogene and therapeutic target. Biochem Pharmacol (2013) 1.08
Protein kinase Cα promotes cell migration through a PDZ-dependent interaction with its novel substrate discs large homolog 1 (DLG1). J Biol Chem (2011) 0.95
Protein kinase C iota as a therapeutic target in alveolar rhabdomyosarcoma. Oncogene (2012) 0.89
Protein kinase C zeta regulates human pancreatic cancer cell transformed growth and invasion through a STAT3-dependent mechanism. PLoS One (2013) 0.86
Basic aspects of tumor cell fatty acid-regulated signaling and transcription factors. Cancer Metastasis Rev (2011) 0.85
Knockout mouse models of insulin signaling: Relevance past and future. World J Diabetes (2014) 0.83
RACK-1 overexpression protects against goniothalamin-induced cell death. Toxicol Lett (2009) 0.82
Protein kinase Cα suppresses Kras-mediated lung tumor formation through activation of a p38 MAPK-TGFβ signaling axis. Oncogene (2013) 0.82
The chromosome 3q26 OncCassette: A multigenic driver of human cancer. Adv Biol Regul (2015) 0.76
Role of PKCbeta in hepatocellular carcinoma cells migration and invasion in vitro: a potential therapeutic target. Clin Exp Metastasis (2008) 0.76
Protein kinase Cδ promotes proliferation and induces malignant transformation in skeletal muscle. J Cell Mol Med (2014) 0.75
PKCι regulates nuclear YAP1 localization and ovarian cancer tumorigenesis. Oncogene (2016) 0.75
Inhibition of PKCα reduces the ability of migration of kidney cancer cells but has no impact on cell apoptosis. Exp Ther Med (2017) 0.75
Downregulation of PKCζ/Pard3/Pard6b is responsible for lung adenocarcinoma cell EMT and invasion. Cell Signal (2017) 0.75
How a growth control path takes a wrong turn to cancer. Science (1998) 21.69
Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene. Science (1992) 10.12
An essential role for Rac in Ras transformation. Nature (1995) 5.34
Targeted disruption of the zetaPKC gene results in the impairment of the NF-kappaB pathway. Mol Cell (2001) 3.05
Interaction codes within the family of mammalian Phox and Bem1p domain-containing proteins. J Biol Chem (2003) 3.02
Amelioration of vascular dysfunctions in diabetic rats by an oral PKC beta inhibitor. Science (1996) 2.80
Atypical protein kinase C iota is an oncogene in human non-small cell lung cancer. Cancer Res (2005) 2.42
Phase I dose escalation and pharmacokinetic study of enzastaurin, an oral protein kinase C beta inhibitor, in patients with advanced cancer. J Clin Oncol (2006) 2.32
Analysis of K-ras, APC, and beta-catenin in aberrant crypt foci in sporadic adenoma, cancer, and familial adenomatous polyposis. Gastroenterology (2001) 2.30
Atypical protein kinase Ciota plays a critical role in human lung cancer cell growth and tumorigenicity. J Biol Chem (2005) 2.05
Molecular cloning and characterization of PKC iota, an atypical isoform of protein kinase C derived from insulin-secreting cells. J Biol Chem (1993) 2.01
Integrative genomic analysis of protein kinase C (PKC) family identifies PKCiota as a biomarker and potential oncogene in ovarian carcinoma. Cancer Res (2006) 1.70
A novel small-molecule inhibitor of protein kinase Ciota blocks transformed growth of non-small-cell lung cancer cells. Cancer Res (2006) 1.67
Protein kinase Ciota is required for Ras transformation and colon carcinogenesis in vivo. J Cell Biol (2004) 1.63
Phase II study of enzastaurin, a protein kinase C beta inhibitor, in patients with relapsed or refractory diffuse large B-cell lymphoma. J Clin Oncol (2007) 1.63
Protein kinase C (PKC) betaII induces cell invasion through a Ras/Mek-, PKC iota/Rac 1-dependent signaling pathway. J Biol Chem (2004) 1.56
Elevated protein kinase C betaII is an early promotive event in colon carcinogenesis. Cancer Res (2001) 1.55
Aurothiomalate inhibits transformed growth by targeting the PB1 domain of protein kinase Ciota. J Biol Chem (2006) 1.55
Primary structures of human protein kinase C beta I and beta II differ only in their C-terminal sequences. FEBS Lett (1987) 1.52
Atypical protein kinase C iota protects human leukemia cells against drug-induced apoptosis. J Biol Chem (1997) 1.49
Overexpression of protein kinase C betaII induces colonic hyperproliferation and increased sensitivity to colon carcinogenesis. J Cell Biol (1999) 1.47
Evidence that atypical protein kinase C-lambda and atypical protein kinase C-zeta participate in Ras-mediated reorganization of the F-actin cytoskeleton. J Cell Biol (1999) 1.46
Identification of nuclear beta II protein kinase C as a mitotic lamin kinase. J Biol Chem (1994) 1.42
Frequent mutations of the beta-catenin gene in mouse colon tumors induced by azoxymethane. Carcinogenesis (2000) 1.39
Tumor promotion by dietary fat in azoxymethane-induced colon carcinogenesis in female F344 rats: influence of amount and source of dietary fat. J Natl Cancer Inst (1984) 1.37
betaII protein kinase C is required for the G2/M phase transition of cell cycle. J Biol Chem (1996) 1.35
BCR-ABL-mediated inhibition of apoptosis with delay of G2/M transition after DNA damage: a mechanism of resistance to multiple anticancer agents. Blood (1995) 1.30
LY317615 decreases plasma VEGF levels in human tumor xenograft-bearing mice. Cancer Chemother Pharmacol (2003) 1.29
Targeted deletion of protein kinase C lambda reveals a distribution of functions between the two atypical protein kinase C isoforms. J Immunol (2004) 1.28
Protein kinase C alpha but not PKCzeta suppresses intestinal tumor formation in ApcMin/+ mice. Cancer Res (2006) 1.27
Selective translocation of beta II-protein kinase C to the nucleus of human promyelocytic (HL60) leukemia cells. J Biol Chem (1991) 1.26
Lifestyle factors and Ki-ras mutations in colon cancer tumors. Mutat Res (2001) 1.19
Effect of diets high in omega-3 and omega-6 fatty acids on initiation and postinitiation stages of colon carcinogenesis. Cancer Res (1991) 1.18
NF-kappaB/RelA transactivation is required for atypical protein kinase C iota-mediated cell survival. Oncogene (2001) 1.13
Effect of different levels of omega-3 and omega-6 fatty acids on azoxymethane-induced colon carcinogenesis in F344 rats. Cancer Res (1988) 1.12
Inhibition of growth of human tumor cell lines in nude mice by an antisense of oligonucleotide inhibitor of protein kinase C-alpha expression. Cancer Res (1996) 1.12
Protein kinase Ciota activity is necessary for Bcr-Abl-mediated resistance to drug-induced apoptosis. J Biol Chem (1999) 1.12
Protein kinase C betaII and TGFbetaRII in omega-3 fatty acid-mediated inhibition of colon carcinogenesis. J Cell Biol (2002) 1.08
Effect of dietary fish oil on azoxymethane-induced colon carcinogenesis in male F344 rats. Cancer Res (1986) 1.07
Protein kinase C isoforms involved in the transcriptional activation of cyclin D1 by transforming Ha-Ras. J Biol Chem (2001) 1.06
Phase III study of gemcitabine and cisplatin with or without aprinocarsen, a protein kinase C-alpha antisense oligonucleotide, in patients with advanced-stage non-small-cell lung cancer. J Clin Oncol (2006) 1.06
Protein kinase C isotypes in human erythroleukemia (K562) cell proliferation and differentiation. Evidence that beta II protein kinase C is required for proliferation. J Biol Chem (1993) 1.02
Protein kinase C isotypes in human erythroleukemia cell proliferation and differentiation. J Cell Sci (1992) 1.02
Efficacy and toxicity of the antisense oligonucleotide aprinocarsen directed against protein kinase C-alpha delivered as a 21-day continuous intravenous infusion in patients with recurrent high-grade astrocytomas. Neuro Oncol (2005) 0.99
The effect of dietary omega-3 fatty acids (fish oil) on azoxymethanol-induced focal areas of dysplasia and colon tumor incidence. Cancer (1990) 0.95
DNA amplification on chromosome 3q26.1-q26.3 in squamous cell carcinoma of the lung detected by reverse chromosome painting. Eur J Cancer (1996) 0.94
Protein kinase CbetaII regulates its own expression in rat intestinal epithelial cells and the colonic epithelium in vivo. J Biol Chem (2004) 0.91
Role of cyclooxygenase 2 in protein kinase C beta II-mediated colon carcinogenesis. J Biol Chem (2002) 0.90
Inhibitory effects of omega-3 fatty acids on protein kinase C activity in vitro. Mol Psychiatry (2001) 0.89
Morphodensitometric analysis of protein kinase C beta(II) expression in rat colon: modulation by diet and relation to in situ cell proliferation and apoptosis. Carcinogenesis (2000) 0.89
Bcr-Abl regulates protein kinase Ciota (PKCiota) transcription via an Elk1 site in the PKCiota promoter. J Biol Chem (2003) 0.88
Protein kinase C-alpha and -beta play antagonistic roles in the differentiation process of THP-1 cells. Cell Signal (2000) 0.87
Mapping of a molecular determinant for protein kinase C betaII isozyme function. J Biol Chem (1998) 0.86
Protein kinase C chimeras: catalytic domains of alpha and beta II protein kinase C contain determinants for isotype-specific function. Proc Natl Acad Sci U S A (1995) 0.85
Decreased PKC-alpha expression increases cellular proliferation, decreases differentiation, and enhances the transformed phenotype of CaCo-2 cells. Cancer Res (1998) 0.84
Action of long-chain fatty acids on protein kinase C activity: comparison of omega-6 and omega-3 fatty acids. Anticancer Res (1992) 0.82
Antitumor activity of a PKC-alpha antisense oligonucleotide in combination with standard chemotherapeutic agents against various human tumors transplanted into nude mice. Anticancer Drug Des (1998) 0.81
Increased translocation of cardiac protein kinase C beta2 accompanies mild cardiac hypertrophy in rats fed saturated fat. J Nutr (2003) 0.80
Protein kinase C isozymes in human megakaryoblastic leukemia cell line, MEG-01: possible involvement of the isozymes in the differentiation process of MEG-01 cells. Br J Haematol (1996) 0.78
A comparison of dietary fish oil and corn oil in experimental colorectal carcinogenesis. Nutr Cancer (1988) 0.77
EGF receptor is required for KRAS-induced pancreatic tumorigenesis. Cancer Cell (2012) 3.19
A novel small-molecule inhibitor of protein kinase Ciota blocks transformed growth of non-small-cell lung cancer cells. Cancer Res (2006) 1.67
Protein kinase Ciota is required for pancreatic cancer cell transformed growth and tumorigenesis. Cancer Res (2010) 1.20
Matrix metalloproteinase-10 is required for lung cancer stem cell maintenance, tumor initiation and metastatic potential. PLoS One (2012) 1.10
Oncogenic K-ras promotes early carcinogenesis in the mouse proximal colon. Int J Cancer (2008) 1.09
Differential expression, distribution, and function of PPAR-gamma in the proximal and distal colon. Physiol Genomics (2007) 1.09
Matrix metalloproteinase-10 promotes Kras-mediated bronchio-alveolar stem cell expansion and lung cancer formation. PLoS One (2011) 0.97
Protein kinase Cbeta is an effective target for chemoprevention of colon cancer. Cancer Res (2009) 0.96
Protein kinase CbetaII regulates its own expression in rat intestinal epithelial cells and the colonic epithelium in vivo. J Biol Chem (2004) 0.91
Role of cyclooxygenase 2 in protein kinase C beta II-mediated colon carcinogenesis. J Biol Chem (2002) 0.90
Protein kinase C iota in the intestinal epithelium protects against dextran sodium sulfate-induced colitis. Inflamm Bowel Dis (2010) 0.88
Protein kinase C zeta regulates human pancreatic cancer cell transformed growth and invasion through a STAT3-dependent mechanism. PLoS One (2013) 0.86
Protein kinase C iota regulates pancreatic acinar-to-ductal metaplasia. PLoS One (2012) 0.85
Characterization of the role of protein kinase C isozymes in colon carcinogenesis using transgenic mouse models. Methods Mol Biol (2003) 0.82
The high affinity peroxisome proliferator-activated receptor-gamma agonist RS5444 inhibits both initiation and progression of colon tumors in azoxymethane-treated mice. Int J Cancer (2008) 0.81